Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies

Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y

(2013) K. H. Nicolaides et al.   PRENATAL DIAGNOSIS

A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood

(2013) N. Guex et al.   PRENATAL DIAGNOSIS

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

(2012) Glenn E. Palomaki et al.   GENETICS IN MEDICINE

Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing

(2012) Tze Kin Lau et al.   Journal of Maternal-Fetal & Neonatal Medicine

Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing

(2012) Diana W. Bianchi et al.   OBSTETRICS AND GYNECOLOGY

Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci

(2012) Bernhard Zimmermann et al.   PRENATAL DIAGNOSIS

Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method

(2012) G. Ashoor et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood

(2011) A. J. Sehnert et al.   CLINICAL CHEMISTRY

DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study

(2011) Glenn E. Palomaki et al.   GENETICS IN MEDICINE

Screening for fetal aneuploidies at 11 to 13 weeks

(2011) Kypros H. Nicolaides   PRENATAL DIAGNOSIS

A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment

(2011) Kypros H. Nicolaides   PRENATAL DIAGNOSIS

Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks

(2011) Argyro Syngelaki et al.   PRENATAL DIAGNOSIS

Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free  -hCG and pregnancy-associated plasma protein-A

(2008) K. O. Kagan et al.   HUMAN REPRODUCTION